Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Share & Growth Graph By 2034. Cancer Immunotherapy Drug ...

From smartwatches to DNA fragments, scientists are building a ‘dashboard’ for human health, but a high-profile trial shows ...

From his perspective, one of the most persistent misconceptions in prostate cancer care relates to how patients interpret ...

A recent randomized clinical trial has found that men with localized, intermediate-risk prostate cancer recovered faster and ...

This may also help explain why coupled men statistically trend toward living ...

New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in Pharmacological Research, show that an innovative drug effectively prevents ...

A systematic review of 29,941 patients shows that preoperative MRI findings significantly improve risk stratification for men with prostate cancer undergoing radical prostatectomy.

Women’s HRT patches can treat prostate cancer just as effectively as standard hormone injections – but with fewer of the worst side-effects – according to a large UK trial published in the New England ...

A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...

Top cancer specialists are urging men to look past the common symptoms of aging and recognize these critical warning signs. It’s often said that if you have your health, you have everything, and there ...

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver hormone therapy, according to the results of a large clinical trial led by UCL ...

Transdermal estradiol (tE2) is an alternative to luteinizing hormone–releasing hormone (LHRH) agonists as androgen-deprivation therapy in patients with prostate cancer. With tE2, testosterone is ...